EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma

doi:10.1016/S1470-2045(19)30669-2

Review

. 2019 Dec;20(12):e715-e728.

doi: 10.1016/S1470-2045(19)30669-2.

EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma

Enrico Franceschi¹, Silvia Hofer², Alba A Brandes¹, Didier Frappaz³, Rolf-Dieter Kortmann⁴, Jacoline Bromberg⁵, Volodia Dangouloff-Ros⁶, Nathalie Boddaert⁶, Elke Hattingen⁷, Benedikt Wiestler⁸, Steven C Clifford⁹, Dominique Figarella-Branger¹⁰, Felice Giangaspero¹¹, Christine Haberler¹², Torsten Pietsch¹³, Kristian W Pajtler¹⁴, Stefan M Pfister¹⁴, Raphael Guzman¹⁵, Walter Stummer¹⁶, Stephanie E Combs¹⁷, Clemens Seidel⁴, Dagmar Beier¹⁸, Martin G McCabe¹⁹, Michael Grotzer²⁰, Florence Laigle-Donadey²¹, Ana S Guerreiro Stücklin²⁰, Ahmed Idbaih²², Matthias Preusser²³, Martin van den Bent⁵, Michael Weller²⁴, Peter Hau²⁵

Affiliations

¹ Department of Medical Oncology, Azienda USL, Bologna, Italy; IRCCS Institute of Neurological Sciences, Bologna, Italy.
² Division of Medical Oncology, Luzerner Kantonsspital, Luzern, Switzerland.
³ Department of Neuro-Oncology and Institut d'Hématologie et d'Oncologie Pédiatrique, Centre Léon Bérard, Lyon, France.
⁴ Department of Radiation Oncology, University Hospital Leipzig, Leipzig, Germany.
⁵ Department of Neuro-Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, Netherlands.
⁶ Paediatric Radiology Department, Hôpital Necker Enfants Malades, Paris, France; UMR 1163, Imagine Institute, Paris, France.
⁷ Department of Neuroradiology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany.
⁸ Department of Neuroradiology, Technical University of Munich Hospital, Munich, Germany.
⁹ Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
¹⁰ Aix-Marseille Univ, APHM, CNRS, INP, Inst Neurophysiopathol, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, Marseille, France.
¹¹ Department of Radiological, Oncological and Anatomopathological Sciences, Policlinico Umberto I, Sapienza University, Rome, Italy; IRCCS Neuromed, Mediterranean Neurological Institute, Pozzilli, Italy.
¹² Institute of Neurology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
¹³ Department of Neuropathology, DGNN Brain Tumour Reference Center, University of Bonn Medical Center, Bonn, Germany.
¹⁴ KiTZ Hopp Children's Cancer Center Heidelberg, Division of Pediatric Neurooncology, DKFZ German Cancer Research Center, DKTK German Cancer Consortium, and Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany.
¹⁵ Department of Neurosurgery, Division of Pediatric Neurosurgery, University Hospital and University Children's Hospital, Basel, Switzerland.
¹⁶ Department of Neurosurgery, University Hospital Muenster, Muenster, Germany.
¹⁷ Department of Radiation Oncology, Technical University of Munich, Munich, Germany; Institute of Radiation Medicine, Department of Radiation Sciences, Helmholtz Zentrum München, Munich, Germany.
¹⁸ Department of Neurology, Odense University Hospital, Odense, Denmark.
¹⁹ Division of Cancer Sciences, University of Manchester, Manchester, UK.
²⁰ Department of Oncology, Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.
²¹ Service de Neurologie 2-Mazarin, Hôpitaux Universitaires La Pitié-Salpêtrière-Charles Foix, Paris, France.
²² Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin, Paris, France.
²³ Division of Oncology, Department of Medicine, Medical University of Vienna, Vienna, Austria.
²⁴ Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland.
²⁵ Wilhelm Sander-NeuroOncology Unit and Department of Neurology, University Hospital Regensburg, Regensburg, Germany. Electronic address: peter.hau@ukr.de.

PMID: 31797797
DOI: 10.1016/S1470-2045(19)30669-2

Review

EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma

Enrico Franceschi et al. Lancet Oncol. 2019 Dec.

. 2019 Dec;20(12):e715-e728.

doi: 10.1016/S1470-2045(19)30669-2.

Authors

Affiliations

¹ Department of Medical Oncology, Azienda USL, Bologna, Italy; IRCCS Institute of Neurological Sciences, Bologna, Italy.
² Division of Medical Oncology, Luzerner Kantonsspital, Luzern, Switzerland.
³ Department of Neuro-Oncology and Institut d'Hématologie et d'Oncologie Pédiatrique, Centre Léon Bérard, Lyon, France.
⁴ Department of Radiation Oncology, University Hospital Leipzig, Leipzig, Germany.
⁵ Department of Neuro-Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, Netherlands.
⁶ Paediatric Radiology Department, Hôpital Necker Enfants Malades, Paris, France; UMR 1163, Imagine Institute, Paris, France.
⁷ Department of Neuroradiology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany.
⁸ Department of Neuroradiology, Technical University of Munich Hospital, Munich, Germany.
⁹ Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
¹⁰ Aix-Marseille Univ, APHM, CNRS, INP, Inst Neurophysiopathol, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, Marseille, France.
¹¹ Department of Radiological, Oncological and Anatomopathological Sciences, Policlinico Umberto I, Sapienza University, Rome, Italy; IRCCS Neuromed, Mediterranean Neurological Institute, Pozzilli, Italy.
¹² Institute of Neurology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
¹³ Department of Neuropathology, DGNN Brain Tumour Reference Center, University of Bonn Medical Center, Bonn, Germany.
¹⁴ KiTZ Hopp Children's Cancer Center Heidelberg, Division of Pediatric Neurooncology, DKFZ German Cancer Research Center, DKTK German Cancer Consortium, and Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany.
¹⁵ Department of Neurosurgery, Division of Pediatric Neurosurgery, University Hospital and University Children's Hospital, Basel, Switzerland.
¹⁶ Department of Neurosurgery, University Hospital Muenster, Muenster, Germany.
¹⁷ Department of Radiation Oncology, Technical University of Munich, Munich, Germany; Institute of Radiation Medicine, Department of Radiation Sciences, Helmholtz Zentrum München, Munich, Germany.
¹⁸ Department of Neurology, Odense University Hospital, Odense, Denmark.
¹⁹ Division of Cancer Sciences, University of Manchester, Manchester, UK.
²⁰ Department of Oncology, Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.
²¹ Service de Neurologie 2-Mazarin, Hôpitaux Universitaires La Pitié-Salpêtrière-Charles Foix, Paris, France.
²² Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin, Paris, France.
²³ Division of Oncology, Department of Medicine, Medical University of Vienna, Vienna, Austria.
²⁴ Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland.
²⁵ Wilhelm Sander-NeuroOncology Unit and Department of Neurology, University Hospital Regensburg, Regensburg, Germany. Electronic address: peter.hau@ukr.de.

PMID: 31797797
DOI: 10.1016/S1470-2045(19)30669-2

Abstract

The European Association of Neuro-Oncology (EANO) and EUropean RAre CANcer (EURACAN) guideline provides recommendations for the diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma. The guideline is based on the 2016 WHO classification of tumours of the CNS and on scientific developments published since 1980. It aims to provide direction for diagnostic and management decisions, and for limiting unnecessary treatments and cost. In view of the scarcity of data in adults with medulloblastoma, we base our recommendations on adult data when possible, but also include recommendations derived from paediatric data if justified. Our recommendations are a resource for professionals involved in the management of post-pubertal and adult patients with medulloblastoma, for patients and caregivers, and for health-care providers in Europe. The implementation of this guideline requires multidisciplinary structures of care, and defined processes of diagnosis and treatment.

PubMed Disclaimer

Comment in

Cerebrospinal fluid evaluation in adult patients with medulloblastoma.
von Bueren AO, Hagel C, Rutkowski S. von Bueren AO, et al. Lancet Oncol. 2020 Mar;21(3):e120. doi: 10.1016/S1470-2045(20)30070-X. Lancet Oncol. 2020. PMID: 32135104 No abstract available.

Cited by

Typical Pediatric Brain Tumors Occurring in Adults-Differences in Management and Outcome.
Greuter L, Guzman R, Soleman J. Greuter L, et al. Biomedicines. 2021 Mar 30;9(4):356. doi: 10.3390/biomedicines9040356. Biomedicines. 2021. PMID: 33808415 Free PMC article. Review.
Recurrent Extraneural Metastatic Medulloblastoma in an Adult Presenting With a Superscan and Treated With Radium-223.
Mou B, Cruz-Lim EM. Mou B, et al. Cureus. 2023 Feb 7;15(2):e34732. doi: 10.7759/cureus.34732. eCollection 2023 Feb. Cureus. 2023. PMID: 36909024 Free PMC article.
Medulloblastoma Presenting as Severe Headache during Pregnancy: A Case Report and Review of the Literature.
Paslaru FG, Panaitescu AM, Nestian E, Iancu G, Veduta A, Paslaru AC, Pop LG, Gorgan RM. Paslaru FG, et al. Medicina (Kaunas). 2022 Jan 14;58(1):127. doi: 10.3390/medicina58010127. Medicina (Kaunas). 2022. PMID: 35056435 Free PMC article. Review.
Tumor Location and Treatment Modality are Associated with Overall Survival in Adult Medulloblastoma.
Ma AK, Freedman I, Lee JH, Miyagishima D, Ahmed O, Yeung J. Ma AK, et al. Cureus. 2020 Feb 20;12(2):e7061. doi: 10.7759/cureus.7061. Cureus. 2020. PMID: 32226663 Free PMC article.
Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experience.
Gregory TA, Mastall M, Lin H, Hess KR, Yuan Y, Martin-Bejarano Garcia M, Fuller GN, Alfaro KD, Gule-Monroe MK, Huse JT, Khatua S, Rao G, Sandberg DI, Wefel JS, Yeboa DN, Paulino AC, McGovern SL, Zaky W, Mahajan A, Suki D, Weathers SP, Harrison RA, de Groot JF, Puduvalli VK, Penas-Prado M, Majd NK. Gregory TA, et al. Neurooncol Adv. 2023 Apr 13;5(1):vdad032. doi: 10.1093/noajnl/vdad032. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37114244 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

13457/CRUK_/Cancer Research UK/United Kingdom

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma

Affiliations

EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma

Authors

Affiliations

Abstract

Comment in

Similar articles

Cited by

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Medical

Abstract

Comment in

Similar articles

Cited by

Publication types

MeSH terms

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Medical